Maclachlan, Ian

Publishing since 2003 (Junior)

Has published 11 publications in 7 years

Number of publications published per year by Maclachlan, Ian. (Source : PubMed)

Distribution of publications types for Maclachlan, Ian. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Judge AD, Robbins M, Tavakoli I, Levi J, Hu L, Fronda A, Ambegia E, McClintock K, MacLachlan I. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J. Clin. Invest. 2009;119;3
Robbins M, Judge A, Ambegia E, Choi C, Yaworski E, Palmer L, McClintock K, MacLachlan I. Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. Hum. Gene Ther. 2008;19;10
Judge A, MacLachlan I. Overcoming the innate immune response to small interfering RNA. Hum. Gene Ther. 2008;19;2
Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JR, Lee AC, Judge A, Jeffs LB, MacLachlan I. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J. Infect. Dis. 2006;193;12
Heyes J, Hall K, Tailor V, Lenz R, MacLachlan I. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. J Control Release 2006;112;2
Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M, Judge AD, Lam K, McClintock K, Nechev LV, Palmer LR, Racie T, Röhl I, Seiffert S, Shanmugam S, Sood V, Soutschek J, Toudjarska I, Wheat AJ, Yaworski E, Zedalis W, Koteliansky V, Manoharan M, Vornlocher HP, MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 2006;441;7089
Heyes J, Palmer L, Bremner K, MacLachlan I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Release 2005;107;2
Jeffs LB, Palmer LR, Ambegia EG, Giesbrecht C, Ewanick S, MacLachlan I. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm. Res. 2005;22;3
Maclachlan I, Cullis P. "Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles" Adv. Genet. 2005;53PA
MacLachlan I, Cullis P. "Diffusible-PEG-lipid stabilized plasmid lipid particles". Adv. Genet. 2005;53

[ See timeline ] [ See all publications ]

h=14

means that Maclachlan, Ian has 14 papers cited a least 14 times - methodology

Key figures

11 pub in 7 years
1.6 publications/year
best year 2005 with 4 pub
h-index 14 with 11 pub
h-ratio : 127 %

See Timeline

Ranking

It's me !

Click here if you are
Maclachlan, Ian.

Most frequent Journals

Gene Ther. (3x)
Med. J. Aust. (2x)
J Control Release (2x)
Hum. Gene Ther. (2x)
Adv. Genet. (2x)

Main affiliation

Protiva Biotherapeutics, 100-3480 Gilmore Way, Burnaby, B.C., Canada V5G 4Y1.

Latest co-workers

Ambegia E Choi C Cullis P Daddario-DiCaprio K Geisbert JB Geisbert TW Heyes J Jeffs LB Judge A Judge AD Kagan E Lee AC McClintock K Palmer L Palmer LR Robbins M Toudjarska I Yaworski E Zedalis W Zimmermann TS

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.